Best Aave Podcasts (2023)

C

Chain Reaction

1
Exclusive: Aave Companies rebrands to Avara and acquires crypto wallet (w/ Stani Kulechov) 24:11

21d ago24:11

24:11

For this week’s episode, Jacquelyn interviewed Stani Kulechov, the founder of Avara, formerly known as Aave Companies. The company is probably best known for Aave protocol, its platform-focused stablecoin GHO and its social network protocol Lens. The web3-focused software technology company announced exclusively on our podcast their rebranding as w…

C

Cell & Gene: The Podcast

1
The Promise of AAV Gene Therapy with REGENXBIO's Ken Mills 28:34

20d ago28:34

28:34

Ken Mills, CEO, President, and Director at REGENXBIO joins Erin Harris for this episode of Cell & Gene: The Podcast to discuss the company's progress with its Phase I/II Affinity Duchenne trial of RGX-202 for the treatment of Duchenne Muscular Dystrophy. They discuss the future of AAV gene therapy as well as achieving scalability with consistent yi…

C

Chain Reaction

1
Crypto VC space may be on the cusp of recovery (w/ David Pakman) 33:00

19m ago33:00

33:00

For this week’s episode, Jacquelyn interviewed David Pakman, managing partner and head of venture investments at CoinFund. Before CoinFund, David spent 14 years at the venture capital firm Venrock. He also led the Series A and B rounds at Dollar Shave Club which was acquired by Unilever for $1 billion. And in 1991, David co-created Apple Music when…

C

Cell & Gene: The Podcast

1
Overcoming the Limitations of CAR T-Cell Therapy with Vittoria Bio's Nick Siciliano, Ph.D. 17:23

2h ago17:23

17:23

Vittoria Biotherapeutics’ CEO, Nick Siciliano, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss the company's mission to expand the applications for CAR-based therapeutics by employing novel cell engineering and gene editing technologies.By Erin Harris

C

Chain Reaction

1
Optimism is optimistic for the future of Ethereum (w/ Jing Wang and Ryan Wyatt) 37:55

7d ago37:55

37:55

For this week’s episode, Jacquelyn interviewed Optimism’s CEO and co-founder Jing Wang and chief growth officer Ryan Wyatt. Optimism is an Ethereum-focused layer-2 blockchain that focuses on scaling and speed, while also lowering costs for users. It helps users interact with Ethereum for about 10x cheaper through its blockchain and provides develop…

F

Frens Validator Crypto Podcast

1
The End Goal of Crypto and How to Fix Our Money - with Ethan Buchman 1:09:41

5d ago1:09:41

1:09:41

What is the end goal of crypto and how can we fix today's money? Dive in for one of the most dense and intense conversations ever held on our podcast! Max is joined by Ethan Buchman, co-founder of Cosmos and CEO of Informal Systems. Together, they discuss how to fix our money, and the end state of crypto, and develop a critique of major economic ph…

T

Talking Rheumatology Research

1
Ep 39. UK JIA Biologics Register: stopping biologics for remission 10:06

6d ago10:06

10:06

What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a …

F

Frens Validator Crypto Podcast

1
$ATOM Maximum Inflation Rate Halving: A Bullcase for Cosmos? 8:56

7d ago8:56

8:56

Governance Proposal 848 passed which will halve the maximum inflation rate of $ATOM, the native cryptocurrency of the Cosmos hub from 20% to 10%. But why did the Cosmos community decide to do so? Is this a bullish sign for $ATOM? What are some takeaways from the recent discussions? This and much more is what we will discuss today! - - - - Catch up …

C

Chain Reaction

1
Amid the OpenAI chaos, here's a refresher on Sam Altman's crypto project: Worldcoin 20:33

14d ago20:33

20:33

For this week’s episode, we're re-sharing Jacquelyn's conversation with Tiago Sada, head of product for Tools for Humanity and core contributor to Worldcoin, at TechCrunch’s Disrupt 2023 in San Francisco. The saga behind Sam Altman’s departure from OpenAI has been a whirlwind, but his involvement in his crypto project Tools for Humanity, the team b…

C

Cell & Gene: The Podcast

1
Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson 25:02

8d ago25:02

25:02

Richard Wilson, Senior Vice President, Primary Focus Lead, Genetic Regulation at Astellas sat down with Cell & Gene: The Podcast's Erin Harris at ARM's 2023 Meeting on the Mesa to discuss the gene therapy deal making landscape as well as Astellas' recent deals and collaborations. They also discussed Astellas' strategic approach since having acquire…

F

Frens Validator Crypto Podcast

1
Should the Cosmos Hub Allocate 600k $ATOM to pStake? - with Mikhil Pandey 39:39

16d ago39:39

39:39

Governance proposal 853 aims to allocate 600k $ATOM to pStake. The pStake protocol is built on top of Persistence. Persistence is a liquid staking blockchain in Cosmos. The proposal aims to make stkATOM more liquid and available across the Cosmos and counter-fight centralizing forces coming from one dominant liquid staking protocol only. But what a…

F

Frens Validator Crypto Podcast

1
All you need to know about the New dYdX Chain - with David Gogel 29:01

23d ago29:01

29:01

The highly anticipated dYdX chain is finally here! At Cosmoverse 2023, we sat down with David Gogel to teach you everything you need to know about the dYdX chain. - - - - - Catch up with FRENS VALIDATOR: 💻 WEBSITE: https://frens.army 📲 FOLLOW ON TWITTER: https://twitter.com/frensvalidator 🌖FOLLOW JURI: https://twitter.com/jurimaibaum - - - - DISCLA…

F

Frens Validator Crypto Podcast

1
From Ripple to Ethereum to Cosmos | Builder's Diary #3 - 0xJim, Co-Founder Catalyst 1:06:59

16d ago1:06:59

1:06:59

For the third episode of Builders´ Diary, we welcome 0xJim from Catalyst to our show! Builder's Diary sheds light on the famous builders behind your favorite crypto project. 0xJim has had an extensive journey in the crypto industry so far. He was an early contributor at Ripple and ENS, then joined AAVE, and is now a builder in the interchain. His n…

F

Frens Validator Crypto Podcast

1
Speculators´ Demise #002 - Jeffrey Hu, Tech Lead at Hashkey Capital 43:54

20d ago43:54

43:54

We welcome Jeffrey Hu, Tech Lead at Hashkey Capital for the second episode of Speculators' Demise. He is also an ambassador of the Cosmos Chinese community, co-hosting several Cosmos dev events. Previously, he was research director at IRIS Network (the first mainnet launched in Cosmos and running Cosmos Chinese community) and chief technical analys…

C

Chain Reaction

1
Former SDNY prosecutor talks about what’s next for SBF post-trial (w/ Brendan Quigley) 23:03

26d ago23:03

23:03

For this week’s episode, Jacquelyn interviewed Brendan Quigley, partner at Baker Botts law firm. Quigley is a former U.S. Marine, now attorney who represents clients on matters related to white-collar government investigations and commercial disputes. Previously, he was a former federal prosecutor as an Assistant U.S Attorney in the U.S. Attorney’s…

F

Frens Validator Crypto Podcast

1
Celestia: The First-Ever Modular Blockchain! (Big $TIA Airdrop) 16:21

23d ago16:21

16:21

What is Celestia and why is everyone so excited about Celestia's recent mainnet launch? Celestia is the first-ever modular blockchain. Modular blockchains separate the consensus and data availability layer from the execution layer. Therefore, modular blockchains differ significantly from today's monolithic blockchains. But how does Celestia's launc…

C

Chain Reaction

1
SBF testifies and closing arguments are made as his trial comes to an end (w/ Alex Wilhelm) 23:38

1M ago23:38

23:38

For this week’s episode, Jacquelyn is joined by TechCrunch+ Editor in Chief, Alex Wilhelm, to discuss the end of the trial for Sam Bankman-Fried, former CEO of FTX, who is facing seven charges related to fraud and money laundering. They talked about: SBF’s testimony The prosecution’s closing arguments The defense’s closing arguments Key points in t…

F

Frens Validator Crypto Podcast

1
Should the Cosmos Hub acquire Blockchains? (feat. Stride, Osmosis & Stargaze) 23:24

1M ago23:24

23:24

Should the Cosmos Hub acquire blockchains? This discussion emerged at Cosmoverse'23 when Stride ($STRD) proposed to merge with the Cosmos Hub. But what would such an acquisition look like? And what about other chains like $OSMO and $STARS? And generally, what is a good strategy for the Hub if it decides to acquire blockchains? This is what we will …

C

Chain Reaction

1
SBF finally takes the stand at his trial (w/ Alex Wilhelm) 24:16

1M ago24:16

24:16

For this bonus episode of Chain Reaction, Jacquie is joined by TechCrunch+ Editor in Chief, Alex Wilhelm, go over the FTX/Sam Bankman-Fried trial before getting into his testimony from Thursday and Friday. They talked about: Why the judge had the jury leave the courthouse for SBF’s testimony Thursday The general feeling of the courthouse on the fou…

F

Frens Validator Crypto Podcast

1
Making $ATOM & the Cosmos Hub Successful! - with Noam Cohen 57:16

1M ago57:16

57:16

How can we make $ATOM successful and find a set role for the Cosmos Hub in the Interchain and the broader crypto industry? And how can we make sure that teams are incentivized to stay in the AEZ and build successful projects? This is what we discussed with Noam Cohen from Binary Builders, a team that is thinking about and working on optimizing the …

C

Cell & Gene: The Podcast

1
Inside 2023 Meeting on the Mesa with ARM's COO, Rita Johnson-Greene 16:33

1M ago16:33

16:33

Alliance for Regenerative Medicine's COO, Rita Johnson-Greene, joined Cell & Gene: The Podcast host, Erin Harris, in person at the 2023 Meeting on the Mesa to discuss this year's event. Johnson-Greene also shared what's ahead for 2024 as the event heads to a new location. They discussed major topics and trends at the event as well as ARM's GROW int…

T

Talking Rheumatology Research

1
Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study 7:19

1M ago7:19

7:19

Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDM…

C

Chain Reaction

1
Former SDNY prosecutor shares what the internet is getting wrong for SBF’s trial (w/ Josh Naftalis) 26:41

1M ago26:41

26:41

For this week’s episode, Jacquelyn interviewed Josh Naftalis, partner at law firm Pallas Partners. He’s a long time attorney who represents companies, boards and executives in cases for white collar criminal defense, regulatory enforcement matters, internal investigations, crisis management and more. Prior to Pallas Partners, Josh was a federal pro…

F

Frens Validator Crypto Podcast

1
Cutting Edge Cosmos DeFi Alpha! >100% APR | Speculators´ Demise #001 - with The Calculator Guy, Dojo Validation, and Levana 42:07

2M ago42:07

42:07

For the first episode of Speculators´ Demise, we welcome The Calculator Guy, Dojo Validation, and Levana to our show! Together, we assess the current Cosmos eco DeFi landscape and leak Alpha on the best yield strategies! - - - - - Follow Stephen (The Calculator Guy), the DeFi Dojo, and Levana: Stephen (The Calculator Guy): https://twitter.com/theca…

C

Chain Reaction

1
FTX collapse and SEC oversteps point to greater need for U.S. crypto regulation (w/ Katherine Dowling) 30:44

2M ago30:44

30:44

For this week’s episode, Jacquelyn interviewed Katherine Dowling, the general counsel and chief compliance officer at Bitwise Asset Management. Bitwise is a crypto asset manager that is known for creating the world’s largest crypto index fund. The firm also filed for a bitcoin spot ETF in the U.S., making it one of a number of firms whose applicati…

T

Talking Rheumatology Research

1
Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes? 12:45

2M ago12:45

12:45

Anika Hoque joins Dr Michael Backhouse to discuss their recent article, which examines the construct validity of the RA foot disease activity index in relationship to musculoskeletal ultrasonography and clinical examination. Listen now to hear the findings, and what this means for future clinical practice and the impact on RA patients at risk for p…

C

Chain Reaction

1
The FTX co-founder and Alameda CEO didn’t hold back at SBF’s trial (w/ Alex Wilhelm) 10:54

2M ago10:54

10:54

This week, we have a bonus mini episode where Jacquelyn talks with TechCrunch+ editor-in-chief Alex Wilhelm to dive back into the Sam Bankman-Fried trial and what has transpired in its second week. Major witnesses who were involved in the downfall of FTX and its sister company Alameda testified like Gary Wang, CTO and cofounder of FTX, and Caroline…

C

Chain Reaction

1
Using blockchain tech to scale businesses and social impact projects (w/ Grace Torrellas) 16:01

2M ago16:01

16:01

For this week’s episode, Jacquelyn interviewed Grace Torrellas, Polygon Labs’ VP of product and zkEVM product lead and co-founder and executive director of Blockchain for Humanity, at TechCrunch’s Disrupt 2023 in San Francisco. Blockchain for Humanity aims to use Bitcoin and blockchain technology to help social impact projects. Separately, Polygon …

C

Cell & Gene: The Podcast

1
The Future of Cell and Organ Transplantation in Treating T1D with Dr. Camillo Ricordi 18:15

2M ago18:15

18:15

A pioneer and an icon in diabetes research, Camillo Ricordi, M.D., is the Professor of Surgery, Director of Cell Transplant Center and Director Emeritus of the Diabetes Research Institute at the University of Miami Miller School of Medicine, Florida (UM-DRI). He joins Cell & Gene: The Podcast's Erin Harris to discuss the biggest and most troubling …

T

Talking Rheumatology Research

1
Ep 36. Trainee Publishing Programme 2023: Dr Charlotte Sharp & Karen Staniland 19:03

2M ago19:03

19:03

Can patients with rheumatoid arthritis examine their own joints? Dr David Liew talks to Dr Charlotte Sharp and Karen Staniland about their work to create a video teaching patients how to self-examine tender and swollen joints. Charlotte is now a consultant rheumatologist based in Manchester and has an interest in applied health research. Karen is t…

C

Chain Reaction

1
SBF's trial has started, and here's what you missed (Chain Reaction x Equity Crossover) 34:13

2M ago34:13

34:13

For this week’s episode, Chain Reaction (and Jacquelyn) did a crossover episode with Alex Wilhelm, editor in chief of TechCrunch+ and co-host of Equity, TechCrunch’s podcast focused on the business of startups. The highly anticipated criminal trial for Sam Bankman-Fried, former CEO of now-bankrupt crypto exchange FTX, started on Tuesday to determin…

T

Talking Rheumatology Research

1
Ep 35. Trainee Publishing Programme 2023: Dr Pallavi Shamdasani 18:07

2M ago18:07

18:07

How can we best diagnose septic arthritis in the acute care setting? Dr Pallavi Shamdasani joins Prof Rene Westhovens to discuss the utility of synovial aspiration and intra-operative synovial fluid and tissue culture for the accurate diagnosis of septic arthritis. Dr Shamdasani is a dual trained rheumatologist and obstetric medicine physician base…

C

Chain Reaction

1
Bonus Episode: Pudgy Penguins’ toys hit Walmart with hopes of expanding NFTs revenue and adoption (w/ Luca Netz) 29:24

2M ago29:24

29:24

This week, we have a bonus episode where Jacquelyn and TechCrunch+ Editor in Chief Alex Wilhelm interviewed Luca Netz, CEO of Pudgy Penguins. Pudgy Penguins, originally known for its flagship collection of 8,888 NFTs that began in 2021 has expanded beyond that into a “IP and brand development company” after Luca bought the project for $2.5 million …

C

Chain Reaction

1
Are you a Worldcoin skeptic? This one’s for you (w/ Tiago Sada) 19:37

2M ago19:37

19:37

For this week’s episode, Jacquelyn interviewed Tiago Sada, head of product for Tools for Humanity and core contributor to Worldcoin, at TechCrunch’s Disrupt 2023 in San Francisco. Tools for Humanity, which is the team building Worldcoin, raised $115 million in a Series C round back in May with investors like Blockchain Capital, a16z, Bain Capital C…

C

Cell & Gene: The Podcast

1
In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg 30:37

2M ago30:37

30:37

Umoja Biopharma's CEO, Andy Scharenberg, M.D., joins Cell & Gene: The Podcast's Erin Harris to discuss the evolution of allogeneic, in vivo CAR-T cell therapeutics. They discuss The Climb, or The Colorado Laboratory and Innovation Manufacturing Building, which is Umoja’s lentiviral vector development and manufacturing facility. They also cover rece…

T

Talking Rheumatology Research

1
Ep 34. Trainee Publishing Programme 2023: Dr Shivani Gor & Dr Sung-Hee Kim 16:34

2M ago16:34

16:34

What is the relationship between COVID-19 vaccination and disease flares in patients with inflammatory arthritis (IA)? Dr Shivani Gor and Dr Sung-Hee Kim join Dr Mwidimi Ndosi to discuss their retrospective study, which used C-reactive protein as a marker to determine the proportion of IA patients who had a flare within four weeks of receiving a va…

C

Chain Reaction

1
Staying strategic during regulatory uncertainty (w/ Chris Lehane) 29:04

3M ago29:04

29:04

For this week’s episode, Jacquelyn did a live interview with Chris Lehane, chief strategy officer at Haun Ventures, at TechCrunch’s Disrupt 2023 in San Francisco. Prior to joining the firm, Chris was an executive at Airbnb. He also co-founded a strategic consultancy firm, Fabiani & Lehane, that advised political, corporate, technology, entertainmen…

T

Talking Rheumatology Research

1
Ep 33. Trainee Publishing Programme 2023: Dr Lauren Huckerby 16:18

2M ago16:18

16:18

What evidence is there for effective transitional care in young people with chronic pain, and what should ideal transitional care look like? Dr Lauren Huckerby joins Dr Diederik De Cock to discuss her recent systematic review - one of the winning papers from the 2023 Rheumatology Advances in Practice Trainee Publishing Programme. Dr Huckerby is a p…

C

Chain Reaction

1
So you want more web3 enterprise adoption? ( w/ Google Cloud, Circle, Chainlink and Xangle panelists) 38:15

3M ago38:15

38:15

Welcome to Chain Reaction. A podcast that unpacks and dives deep into the latest trends, drama and news in crypto with some of the biggest names in the industry to break things down block by block for the crypto curious. For this week’s episode, Jacquelyn is sharing a panel she moderated live at Avalanche House, while she was in Seoul, South Korea …

C

Cell & Gene: The Podcast

1
Inside Genome Editing with CBER's Dr. Peter Marks 25:17

3M ago25:17

25:17

The FDA's Center for Biologics Evaluation and Research (CBER)'s Dr. Peter Marks makes his second appearance on Cell & Gene: The Podcast. This time Dr. Marks talks to Host, Erin Harris, about base editing and prime editing and their potential to meet unmet medical need. They discuss what clinical holds say about the FDA’s views on gene editing. They…

T

Talking Rheumatology Research

1
Ep 32. Trainee Publishing Programme 2023: Dr Cristiana Sieiro Santos 11:22

3M ago11:22

11:22

Can we classify the clinical phenotype of systemic sclerosis by autoantibodies? Dr Cristiana Sieiro Santos joins Dr Anastasia Madenidou to discuss her recent article - one of the winning papers from the 2023 Rheumatology Advances in Practice Trainee Publishing Programme. Dr Sieiro Santos is currently a rheumatology trainee at Complejo Asistencial U…

C

Chain Reaction

1
OG Bitcoiner on the blockchain’s evolution, investing and need for regulatory clarity (w/ Charlie Shrem) 32:15

3M ago32:15

32:15

Welcome to Chain Reaction. A podcast that unpacks and dives deep into the latest trends, drama and news in crypto with some of the biggest names in the industry to break things down block by block for the crypto curious. For this week’s episode, Jacquelyn interviewed Charlie Shrem, founder of the Bitcoin Foundation, general partner at Druid Venture…

T

Talking Rheumatology Research

1
Ep 31. Are AAV patients at an increased risk of stroke? 8:18

3M ago8:18

8:18

Dr Aladdin J Mohammad joins Dr Marwan Bukhari to discuss their article, chosen as the August Editor's Choice article, which determines the incidence rate, predictors and outcome of stroke in a population-based cohort of individuals with ANCA-associated vasculitis. Listen now to hear the findings and what this means for future clinical practice! You…

C

Chain Reaction

1
Americans may get a bitcoin spot ETF soon (w/ Craig Salm) 14:15

3M ago14:15

14:15

Welcome to Chain Reaction. A podcast that unpacks and dives deep into the latest trends, drama and news in crypto with some of the biggest names in the industry to break things down block by block for the crypto curious. For this week’s news episode, Jacquelyn interviewed Craig Salm, chief legal officer at Grayscale Investments. Grayscale is a digi…

C

Cell & Gene: The Podcast

1
The Future of CAR-T with Bristol Myers Squibb's Lynelle Hoch 25:53

3M ago25:53

25:53

As SVP Cell Therapy Franchise Lead at Bristol Myers Squibb, Lynelle Hoch leads her team to bring more curative cell-based therapies to patients. She joins Cell & Gene: The Podcast's Host, Erin Harris, to discuss the near-term future of CAR-T. They also take a deep dive into the various innovations and patient access progress being made in both soli…

T

Talking Rheumatology Research

1
Ep 30. Diagnosing cocaine-induced vasculitis 12:34

3M ago12:34

12:34

How can you differentiate between cocaine-induced and ANCA-associated vasculitis? Dr Sander van Leuven joins Dr David Liew to discuss a recent case series analysis from centres in Birmingham and London. Sander is a consultant rheumatologist in Nejmegen, the Netherlands. He previously trained in London, where he conducted a 15-year retrospective stu…

C

Chain Reaction

1
Blockstream is still betting on Bitcoin and mining it (w/Erik Svenson) 21:14

3M ago21:14

21:14

A podcast that unpacks and dives deep into the latest trends, drama and news in crypto with some of the biggest names in the industry to break things down block by block for the crypto curious. For this week’s episode, Jacquelyn interviewed Erik Svenson, co-founder, president and chief financial officer at Blockstream, a bitcoin and blockchain-focu…

C

Chain Reaction

1
A bitcoin spot ETF could open the floodgates for greater crypto demand (w/ Eric Balchunas) 24:17

4M ago24:17

24:17

A podcast that unpacks and dives deep into the latest trends, drama and news in crypto with some of the biggest names in the industry to break things down block by block for the crypto curious. For this week’s news episode, Jacquelyn talks with Eric Balchunas, senior ETF analyst at Bloomberg, alongside TechCrunch+ editor-in-chief Alex Wilhelm. Balc…

C

Cell & Gene: The Podcast

1
The Promise of Genome Editing with Caribou Biosciences' Rachel Haurwitz, Ph.D. 23:21

4M ago23:21

23:21

On this episode of Cell & Gene: The Podcast, Rachel Haurwitz, Ph.D., CEO at Caribou Biosciences joins Host Erin Harris to discuss the evolution of genome editing, its present state, as well as its undeniable potential. They also discuss Caribou's chRDNA genome editing technology and how it differs from CRISPR-Cas9.…

F

Frens Validator Crypto Podcast

1
Builders' Diary #2 - Dean Tribble, CEO of Agoric 52:31

4M ago52:31

52:31

For the second episode of Builders´ Diary, we welcome Dean Tribble to our show! Dean has been working on smart contracts since before you were even born, and he is the CEO of Agoric, which aims to onboard millions of JavaScript developers to crypto. Tune in to learn Dean's unique take on crypto´s largest challenges, if there is more to our space th…

Podcasts Worth a Listen

Aave Podcasts

Podcasts Worth a Listen

Quick Reference Guide